![](Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination. Molecular Gates are small molecule drugs that selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease." name="description"/><meta content="GateBioscience" property="og:title"/><meta content="Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination. Molecular Gates are small molecule drugs that selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease." property="og:description"/><meta content="https://cdn.prod.website-files.com/651ef47f48428a3c2cd4108a/654c13fb532c4467e354569b_1005.svg)
Gate Bioscience
A new class of small molecule therapeutics: Molecular Gates
California, United States · Founded 2021 · $125.0M raised
- Headquarters
- California, California
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- gatebio.com
- Total Funding
- $125.0M
- Last Round
- $65.0M Series BNov 2025
- Rounds
- 3
About
Gate Bioscience creates a new class of small molecule therapeutics called Molecular Gates. Backed by a16z, Forbion, Versant. 2025 collaboration with Eli Lilly following $65M Series B.
Summary
Gate Bioscience is a Biotech company based in California, United States, founded in 2021. It has raised $125.0M in total across 3 rounds, most recently a $65.0M Series B round in Nov 2025. Investors include Forbion Capital Partners, Jerel Davis and Andreessen Horowitz.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Clinical-stage precision medicines company using protein-motion-driven drug discovery to design s...
Biotechnology company that discovers and develops medicines for serious, life-threatening disease...